The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ontozry



Angelini Pharma Italia S.P.A.EU/1/21/1530/008-010

Main Information

Trade NameOntozry
Active SubstancesCenobamate
Dosage FormFilm-coated tablet
Licence HolderAngelini Pharma Italia S.P.A.
Licence NumberEU/1/21/1530/008-010

Group Information

ATC CodeN03AX Other antiepileptics
N03AX25 Ontozry

Status

License statusAuthorised
Licence Issued26/03/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back